Targeting apoptosis pathways in cancer stem cells.

Area of Science:

• Oncology
• Cancer Biology
• Molecular Medicine

Background:

• Tumor formation and progression mechanisms remain incompletely understood.
• Cancer cell hierarchy, including cancer stem cells (CSCs), has been identified in various tumors.
• CSCs possess self-renewal and differentiation capabilities, offering new therapeutic targets.

Purpose of the Study:

• To explore the challenges in therapeutically targeting cancer stem cells (CSCs).
• To review mechanisms of CSC resistance to apoptosis and current therapeutic strategies.
• To emphasize the need for better molecular characterization of CSCs for improved cancer treatment.

Main Methods:

• Review of existing literature on cancer stem cells, apoptosis, and targeted therapies.
• Discussion of molecular pathways involved in CSC survival and apoptosis evasion.
• Analysis of clinical trial data for apoptosis-inducing agents and targeted therapies.

Main Results:

• CSCs exhibit resistance to apoptosis, a key mechanism for tumor survival.
• Targeted therapies, including TRAIL receptor agonists and IAP inhibitors, show promise but face challenges.
• The EGF-R/Akt pathway is a frequent target for indirect apoptosis induction.

Conclusions:

• Effective targeting of CSCs is hindered by their resistance to apoptosis and lack of reliable clinical models.
• Further molecular characterization of CSCs is essential to identify stimuli that induce their death.
• Developing more effective cancer treatments requires a deeper understanding of CSC biology and resistance mechanisms.